Company: LHI
Filing Date: 2025-05-23
Form Type: F-1
Source: 0001213900-25-046955
Chunk: 4

Company: Living Homeopathy International Ltd.
Filing Date: 2025-05-23
Form: F-1
Chunk 4
---
 is a national law of the PRC and the constitutional document for Hong Kong, national laws of the PRC shall not be applied in Hong Kong except for those listed in Annex III of the Basic Law and applied locally by promulgation or local legislation. The Basic Law expressly provides that the national laws of the PRC which may be listed in Annex III of the Basic Law shall be confined to those relating to defense and foreign affairs as well as other matters outside the autonomy of Hong Kong. The basic policies of the PRC regarding Hong Kong as a special administrative region of the PRC are reflected in the Basic Law, providing Hong Kong with a high degree of autonomy and executive, legislative and independent judicial powers, including that of final adjudication under the principle of “one country, two systems.”

However, in light of the
PRC government’s recent expansion of authority in Hong Kong, we may be subject to uncertainty about any future actions of the PRC
government or authorities in Hong Kong, and it is possible that all the legal and operational risks associated with being based in, and
having operations in, mainland China may also apply to operations in Hong Kong at any time and with little or no advance notice. There
is no assurance that there will not be any changes in the economic, political and legal environment in Hong Kong. The PRC government
may intervene or influence our current and future operations in Hong Kong at any time with little or no advance notice or may exert more
control over offerings conducted overseas and/or foreign investment in issuers like us. Such governmental actions, if and when they occur:
(i) could significantly limit or completely hinder our ability to continue our operations; (ii) could significantly limit or completely
hinder our ability to offer or continue to offer our Class A Ordinary Shares to investors; and (iii) may cause the value of our Class
A Ordinary Shares to significantly decline or become worthless.

We are also aware that
recently, the government of mainland China initiated a series of regulatory actions and statements to regulate business operations in
certain areas in mainland China with little or no advance notice, including cracking down on illegal activities in the securities market,
enhancing supervision over mainland Chinese companies listed overseas using a VIE structure, adopting new measures to extend the scope
of cybersecurity reviews, and expanding the efforts in anti-monopoly enforcement. Since these statements and regulatory actions are new,
it is highly uncertain how soon the legislative or administrative regulation making bodies will respond and what existing or new laws
or regulations or detailed